Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Advanced Life Sciences Holdings (ADLS)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for ADLS as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
1.94M
LOW
EBITDA
►
-9.36M
AVG
Net Income
►
-10.7M
AVG
Revenue Growth
►
5973.3%
VERY HIGH
Operating Margin
►
-482.3%
AVG
Net Margin
►
-539.4%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-1.90
Current Ratio
►
0.862
LOW
Quick Ratio
►
0.862
LOW
Interest Coverage Ratio
►
-9.60
AVG
Book Value Per Share
►
-0.105
Cash Per Share
►
0.0521
Loading...
STOCK SUMMARY
Open
0.22
Day Range
0.22
-
0.23
52 Week Range
0.14
-
1.62
Volume
749K
Avg Volume (3 mo)
1.14M
Shares Outstanding
82.6M
Market Cap
17.3M
VALUATION
Price to Earnings (P/E)
►
-1.71
Price to Book (P/B)
►
-2.14
Price to Sales (P/S)
►
9.24
AVG
Return on Assets (ROA)
►
-115.6%
LOW
Return on Equity (ROE)
►
-1947.5%
VERY LOW
EV/EBITDA
►
-3.49
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0.1%
Held by insiders
80.5%
Held by institutions
0.4%
No Sales Breakout Data.